Sana Biotechnology, Inc. - 10-Q Filing
Sana Biotechnology filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to contingent liabilities from acquisitions such as Cobalt Biomedicine Inc., including fair value measurements of these obligations using Level 3 inputs.
Tickers: $SANA